Deerland Probiotics & Enzymes has announced it has received FSSC 22000 certification as part of the company’s initiatives to be compliant with FDA’s new Food Safety Modernization Act of 2011 (FSMA). The certificate is applicable for the scope of design, development, manufacturing, packaging, testing and shipping of dietary supplements, feed supplements and other enzyme and probiotic-based formulations for human and animal consumption.
Deerland Probiotics & Enzymes announced on July 19th that the company had acquired National Enzyme Company (NEC). We believe this investment will allow us to bring even greater value to our customers and to the enzyme and probiotic industries we serve.
Deerland to Present Initial Results from Clinical Trial on DE111® Probiotic at the ISSN Sports Nutrition Conference
Deerland will share results from their latest clinical study at the International Society of Sports Nutrition (ISSN) 15th Annual Conference and Expo, which is held from June 7 to 9, 2018 in Clearwater Beach, FL. Dr. Jeremy R. Townsend of Lipscomb University in Nashville, TN will present preliminary data on Deerland’s exclusive strain of Bacillus subtilis DE111 titled “The Effect of Probiotic Supplementation on Markers of Immune and Endocrine Status in Division I Baseball Players.”
Deerland Probiotics & Enzymes has introduced a new, more soluble form of its hardy probiotic strain DE111®. This form of the spore-producing probiotic Bacillus subtilis, DE111® HS (Highly Soluble), makes it easier to introduce probiotics into high-growth natural product markets like hot beverages, functional drinks, and nutritional supplement gummies.
Deerland Probiotics & Enzymes has announced that its proprietary strain of Bacillus subtilis DE111 has been granted non-Novel Food ingredient status in Canada. A letter of non-objection has been received from Health Canada, confirming that DE111 is not considered a Novel Food and may be sold as a food ingredient.
About Deerland Probiotics & Enzymes
Deerland Probiotics & Enzymes, based in Kennesaw, Ga., specializes in customized enzyme and probiotic-based formulations, collaborating with customers to develop innovative and often proprietary solutions. In addition to customized formulations, the company offers a line of university and clinically studied branded products. Deerland provides regulatory support and also performs specialty contract manufacturing services, including bulk blends, liquids, hard shell capsules, and tablets; as well as bottling and labeling. To contact Deerland Probiotics & Enzymes, call 800.697.8179 or email info@DeerlandEnzymes.com.
Deerland will introduce its newest branded product, Solarplast® at this year’s Engredea/Expo West trade show in Anaheim, CA. Solarplast is an extract of organic dark leafy greens, which is enzymatically enhanced by a unique and proprietary manufacturing process. It utilizes the power of the chloroplasts found in dark leafy greens to provide a rich source of molecular chaperones and antioxidants, all in a naturally occurring lipid protective coating.
Researchers have found that consumption of Deerland Probiotics & Enzymes’ probiotic strain DE111® can improve occasional constipation and/or diarrhea in healthy individuals, according to a study recently published in the Journal of Probiotics & Health.
Deerland Probiotics & Enzymes is pleased to announce that it has earned Non-GMO Project verification for Dairylytic® and Glutalytic®, the company’s branded enzyme blends for dairy and gluten digestion.
Deerland Probiotics & Enzymes is pleased to announce that it has received a notice of allowance for its US patent application directed to prebiotic compositions comprising bacteriophages, namely Deerland’s branded prebiotic, PreforPro.
Deerland Probiotics & Enzymes is pleased to announce that it has earned Non-GMO Project verification for ProHydrolase, the company’s branded enzyme blend for protein digestion.